Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antimycobacterial antibodies in sera from patients throughout the clinico-pathological disease spectrum of leprosy.

× No keyword cloud information.

10 in total

1. Mycobacterium paratuberculosis antigen D: characterization and evidence that it is a bacterioferritin.

Authors: B W Brooks; N M Young; D C Watson; R H Robertson; E A Sugden; K H Nielsen; S A Becker
Journal: J Clin Microbiol Date: 1991-08 Impact factor: 5.948

2. Circulating complexes in leprosy studied by the platelet aggregation test. The platelet aggregation test and its relation to the Rubino test and other sero-immunological parameters in 135 patients with leprosy.

Authors: O Wager; K Penttinen; J D Almeida; D V Opromolla; T Godal; G Kronvall
Journal: Clin Exp Immunol Date: 1978-12 Impact factor: 4.330

3. Production and assay of antibodies against one antigenic component of Mycobacterium bovis BCG.

Authors: M Harboe; O Closs; K Svindahl; J Deverill
Journal: Infect Immun Date: 1977-05 Impact factor: 3.441

4. In vitro synthesis of humoral factors (immunoglobulins and complement) in lesional skin of leprosy patients.

Authors: R F Lai A Fat; J C Jin; M Diesselhoff-den Dulk; R van Furth
Journal: Infect Immun Date: 1979-09 Impact factor: 3.441

5. Humoral immunity in leprosy: immunoglobulin G and M antibody responses to Mycobacterium leprae in relation to various disease patterns.

Authors: J Touw; E M Langendijk; G L Stoner; A Belehu
Journal: Infect Immun Date: 1982-06 Impact factor: 3.441

6. Effect of cyclophosphamide treatment on the course of Mycobacterium lepraemurium infection and development of delayed-type hypersensitivity reactions in C57B1 and BALB/c mice.

Authors: J Alexander
Journal: Clin Exp Immunol Date: 1978-10 Impact factor: 4.330

Antimycobacterial antibodies in sera from patients throughout the clinico-pathological disease spectrum of leprosy.

1. Mycobacterium paratuberculosis antigen D: characterization and evidence that it is a bacterioferritin.

2. Circulating complexes in leprosy studied by the platelet aggregation test. The platelet aggregation test and its relation to the Rubino test and other sero-immunological parameters in 135 patients with leprosy.

3. Production and assay of antibodies against one antigenic component of Mycobacterium bovis BCG.

4. In vitro synthesis of humoral factors (immunoglobulins and complement) in lesional skin of leprosy patients.

5. Humoral immunity in leprosy: immunoglobulin G and M antibody responses to Mycobacterium leprae in relation to various disease patterns.

6. Effect of cyclophosphamide treatment on the course of Mycobacterium lepraemurium infection and development of delayed-type hypersensitivity reactions in C57B1 and BALB/c mice.

7. Specific and nonspecific resistance in mice immunized with irradiated Myobacterium leprae.

8. Lipoarabinomannan and lipid-free arabinomannan antigens of Mycobacterium paratuberculosis.

9. Antibodies against BCG antigen 60 in mycobacterial infection.

10. In vitro synthesis of anti-mycobacterial antibodies in biopsies from skin lesions of leprosy patients.